First U.S. Face Transplant Recipient Recou... ( 46-year-old woman lost most of mid-fa...)

First U.S. Face Transplant Recipient Recounts Ordeal

Date:5/6/2009

46-year-old woman lost most of mid-face area in gun blast

WEDNESDAY, May 6 (HealthDay News) --The recipient of the first face transplant done in the United States has stepped forward to reveal the results of her surgery.

Connie Culp, a 46-year-old Ohio woman, lost a large part of her face in 2004 when her husband shot her in the face, then turned the gun on himself. He went to prison for seven years. According to the Associated Press, the gunshot destroyed Culp's nose, cheeks, the roof of her mouth and one eye and left hundreds of bone fragments and shotgun pellets lodged in her face. Only her upper eyelids, forehead, lower lip and chin remained. Culp could not breathe without the aid of a tube inserted into her windpipe.

But now a 22-hour face transplant operation -- conducted Dec. 10 and led by Dr. Maria Siemionow of the Cleveland Clinic -- may have given Culp a new lease on life.

Her expressions are still a bit wooden, and her face has a bulky, squarish look. But doctors say subsequent operations -- performed once her circulation and nerves begin to grow -- should improve her appearance further.

"I guess I'm the one you came to see today," Culp, a mother of two and grandmother of two preschoolers, said Tuesday at a news conference at the Cleveland Clinic. Now able to talk, smile, smell and taste food, Culp said that it's "more important that you focus on the donor family that made it so I could have this person's face."

No information is being released about the female donor and how she died, but Culp said the deceased woman's family were moved when they viewed before-and-after pictures of Culp's transformation.

The face transplant was the fourth performed in the world (the first was for a French woman, Isabelle Dinoire, in 2005) and the most extensive ever performed, according to the AP.

Culp's identity and the nature of her injuries had been kept secret un
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility

Post Your Comments:

Related Image:

First U.S. Face Transplant Recipient Recounts Ordeal

(Date:5/18/2013)... According to the the Stevens Johnson Syndrome Foundation, Stevens ... a severe allergic reaction usually to medicine (i). The ... quickly advance causing blistering and large areas of dead skin. ... can develop at any time and seriously affect both children ... Bol, passed away after he received kidney medicine which caused ...

(Date:5/18/2013)... 2013 The product liability attorneys at Wright ... behalf of consumers nationwide who have sustained serious tendon injuries ... These cases are all part of MDL 2308 and were ... will be heard in the U.S. District Court of ... & Schulte, LLC specializes in defending the rights of those ...

(Date:5/17/2013)... 17, 2013 Daily Gossip announced on Monday ... creator of the Program Yourself Thin regime, Jim ... online website by the end of the month in order ... successfully reeducate themselves and lead a healthy lifestyle, free of ... Thin package is available for only $97 and it ...

(Date:5/17/2013)... 17, 2013 Degenerative changes to the area ... felt with compression, known as the nucleus pulposus, has been ... a new study led by researchers at the Icahn School ... the journal PLOS ONE, reinforces the importance of diabetes in ... it is the first study to demonstrate that these changes ...

(Date:5/17/2013)... York, New York (PRWEB) May 17, 2013 ... firm dedicated to protecting the rights of victims injured ... (J&J)’s DePuy Orthopaedics Inc. has said in a May ... selling some of its metal-on-metal and ceramic-on-metal hip replacement ... Articulation and the Complete Ceramic-on-Metal Acetabular Hip System will ...

Breaking Medicine News(10 mins):Health News:Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome 2 Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 2 Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 3 Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 4 Health News:Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine 2 Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 2 Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 3 Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 4 Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 2 Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 3

[0] Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome [0] Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups [0] Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine [0] Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice [0] Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products

... TAMPA, Fla., Nov. 2 Romark Laboratories, ... phase II clinical trial showing that 79% of ... nitazoxanide plus,the standard of care had a sustained ... weeks following treatment, compared to 43%,of patients receiving ...

... Kensey Nash Corporation,(Nasdaq: KNSY ) today ... Optical Coherence Domain Reflectometry Guidewire, from Lawrence,Livermore National ... related to its chronic total occlusion (CTO) platform.,The ... capabilities,allowing it to sense locations, thickness, and structure ...

... Amedisys, Inc.,(Nasdaq: AMED or the "Company"), one of America,s ... Graham, President and,Chief Operating Officer, and Dale E. Redman, ... Markets 18th Annual Healthcare Conference in,New York on Tuesday, ... 9:10 a.m. Eastern time. The audio,presentation will be webcast ...

... Nov. 2 NxStage Medical, Inc.,(Nasdaq: NXTM ), ... machine, today announced its financial results for the,third quarter ... quarter of 2007 were $11.6 million, compared to,$5.5 million ... 111%. Revenues in,the chronic home dialysis market were $8.3 ...

... 2 Vista Partners announced,today that it has ... RPTP). "We believe Raptor,s operational approach will serve,as ... as it promotes,operational efficiency, reduced operating costs and ... a Phase II candidate for 2008 in,Convivia(TM), which ...

... (Nasdaq: KOSN ) will announce its third ... after market close. The announcement of Kosan,s ... a conference call and live webcast on November ... Eastern. Interested parties may access the,live call by ...

Cached Medicine News:Health News:Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C 2 Health News:Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C 3 Health News:Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C 4 Health News:Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform 2 Health News:Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform 3 Health News:Amedisys to Present at 2007 CIBC Healthcare Conference in New York 2 Health News:NxStage Medical Reports Third Quarter 2007 Results 2 Health News:NxStage Medical Reports Third Quarter 2007 Results 3 Health News:NxStage Medical Reports Third Quarter 2007 Results 4 Health News:NxStage Medical Reports Third Quarter 2007 Results 5 Health News:NxStage Medical Reports Third Quarter 2007 Results 6 Health News:NxStage Medical Reports Third Quarter 2007 Results 7 Health News:NxStage Medical Reports Third Quarter 2007 Results 8 Health News:Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp. 2 Health News:Kosan Announces November 8, 2007 Conference Call and Webcast of Third Quarter 2007 Financial Results 2

Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform Amedisys to Present at 2007 CIBC Healthcare Conference in New York NxStage Medical Reports Third Quarter 2007 Results Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp.Kosan Announces November 8, 2007 Conference Call and Webcast of Third Quarter 2007 Financial Results

(Date:5/17/2013)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... systems, announced today that the United States Food and ... Drug application(IND) for ORMD-0801, its oral insulin capsule. ... clearance to proceed," stated Nadav Kidron ... major milestone for Oramed and we look forward to ...

(Date:5/16/2013)... ZURICH , May 17, 2013 ... Technology and Research (A*STAR) and Switzerland,s ... has been dosed in a Phase 1 clinical trial with ... Qbeta virus-like particle (VLP) technology. In this first Phase 1 ... candidate and its potential to protect against H1N1 influenza infection ...

(Date:5/16/2013)... Therapeutics, (Nasdaq: NKTR ) President and Chief Executive ... to present at the upcoming 2013 UBS Global Healthcare Conference ... New York Hotel on Tuesday, May 21, 2013 at 10:00 ... via a Webcast through a link posted in the Investor ... . This Webcast will be available for replay until June ...

Breaking Medicine Technology:Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2 Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6 Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2

[0] Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.[0] A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing [0] Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City

... Inc. (NYSE: WLP ) announced today that ... the Centers for Medicare & Medicaid Services (CMS) to ... (DME MAC) for Jurisdiction B, which includes the states ... National Government Services was originally awarded ...

... Inc. (OTC Bulletin Board: AEMD ), ... address infectious disease and cancer, disclosed today that ... Hemopurifier® within U.S. Government programs that support the ... threats. The Aethlon Hemopurifier® is the first medical ...

Cached Medicine Technology:WellPoint Subsidiary Wins Durable Medical Equipment Medicare Administrative Contract Valued at $86.7 Million 2 Aethlon Medical Reestablishes Biodefense Programs 2 Aethlon Medical Reestablishes Biodefense Programs 3 Aethlon Medical Reestablishes Biodefense Programs 4 Aethlon Medical Reestablishes Biodefense Programs 5 Aethlon Medical Reestablishes Biodefense Programs 6

WellPoint Subsidiary Wins Durable Medical Equipment Medicare Administrative Contract Valued at $86.7 Million Aethlon Medical Reestablishes Biodefense Programs

60 month warranty, constructed entirely of aluminum alloy, allows the selection of 11 units of measure....

Inquire...

Thermometer for Round Water Bath...

... The F340 is a basic laboratory system ... pH results can be obtained when used ... 3-in-1 electrode. • Fast and easy one ... recognition for five buffers (pH 1.68, 4.00, ...

Medicine Products:

A&D HF-410 Thermometer - No Mercury Thermometer for Round Water Bath F 340 pH / Temp Meter/Electrode Package, 220V, U.K. Plug